,feature,Maximum hospitalization rate | corr,Maximum hospitalization rate | p-value,If hospitalization threshold passed | corr,If hospitalization threshold passed | p-value
0,Obs: Incidence rate,0.4518094563877939,1.8423523367530393e-51,0.6042538320199031,1.453806764249725e-100
1,Obs: Incidence rate-ave-2wk,0.4134932587865709,1.4077476263919374e-42,0.566265278020873,7.261002629994257e-86
2,Obs: Incidence rate-slope-4wk,0.5173192852680347,1.5525741849919185e-69,0.6511620083130949,1.0822010485234708e-121
3,Obs: New hospitalization rate,0.5563196424170181,2.5194716777502605e-82,0.418964787867753,8.890646433345263e-44
4,Obs: New hospitalization rate-ave-2wk,0.514000388336628,1.6006404764064054e-68,0.39050741122749877,8.932694275976342e-38
5,Obs: New hospitalization rate-slope-4wk,0.6323186395313773,9.134418254858695e-113,0.5089369390922002,5.354740429634968e-67
6,Obs: % of new hospitalizations that are vaccinated,-0.04060235604072486,0.19953328514918742,-0.035277769746850214,0.26505073587270894
7,Obs: % of new hospitalizations that are vaccinated-ave-2wk,-0.06190463250456909,0.05034451305811894,-0.02600550506192591,0.4113748162990206
8,Obs: % of new hospitalizations that are vaccinated-slope-4wk,0.029316751598417935,0.35438537120451413,-0.014814276243689677,0.6398501667712905
9,Obs: % of incidence due to novel variant,0.31144579053395627,6.215590937983531e-24,0.5099356488492811,2.692074557373407e-67
10,Obs: % of incidence due to novel variant-ave-2wk,0.292385138845511,3.673196966664878e-21,0.49634806800373815,2.567814900939174e-63
11,Obs: % of incidence due to novel variant-slope-4wk,0.5164923456709477,2.7833066192489743e-69,0.4544527741316211,4.069869017573238e-52
12,Obs: % of new hospitalizations due to novel variant,0.30389910124880654,8.232701265610704e-23,0.4669622247174568,2.6713006332458084e-55
13,Obs: % of new hospitalizations due to novel variant-ave-2wk,0.2953423629848878,1.4077057843943835e-21,0.47937626083552737,1.3641102168937377e-58
14,Obs: % of new hospitalizations due to novel variant-slope-4wk,0.27713912489500514,4.321827722985215e-19,0.2891029761833958,1.0510770778531461e-20
15,Obs: % of new hospitalizations due to Novel-V,0.05576504155951589,0.07796602752068255,0.12489194629604139,7.494829934863063e-05
16,Obs: % of new hospitalizations due to Novel-V-ave-2wk,0.059271646472453726,0.06098045013430856,0.1771545126901642,1.7027161237505268e-08
17,Obs: % of new hospitalizations due to Novel-V-slope-4wk,0.04541772336089312,0.15123614986873044,0.01336441474295326,0.6729446025564935
18,Obs: Cumulative hospitalization rate,0.3353317397659403,1.0526658739350168e-27,0.2939194732915785,2.236351371207765e-21
19,Obs: Cumulative vaccination rate,0.023578589560204605,0.45639780423890725,0.2921887291550443,3.913235225428216e-21
20,Obs: Prevalence susceptible,0.07929060161220872,0.012134700288925075,-0.026005574602914656,0.4113735651148675
21,R0,0.02538635133156676,0.4226038108213759,0.038696955602718484,0.22146848764363175
22,Duration of infectiousness-dominant,-0.027928947963911523,0.37763710993573246,-0.004224899161933272,0.8938481506683028
23,Prob novel strain params-0,-0.017877179764528104,0.5723022424034562,0.00024278831138339115,0.9938818507684123
24,Prob novel strain params-1,0.0579417375941307,0.0670220983567438,0.06094647758027541,0.054019823956700616
25,Prob novel strain params-2,-0.00698401714366648,0.8254191033184914,0.011805291442578919,0.7092510267313942
26,Ratio infectiousness duration of novel to dominant,0.07264670878905963,0.021592910661622073,0.041519898472469396,0.1895545393266054
27,Duration of vaccine immunity,0.05814427416841952,0.06607142600091655,0.04612044446891531,0.14500380393373077
28,Ratio of duration of immunity from infection+vaccination to infection,0.003777733655163187,0.9050270366328121,0.0025218938723186868,0.9365158903592082
29,Vaccine effectiveness against infection-0,0.014906134969281792,0.6377764393187497,0.01025375584102848,0.7460476664099541
30,Vaccine effectiveness against infection-1,0.001123945073592659,0.9716827832468428,0.000436297535844914,0.9890057507656174
31,Ratio transmissibility of novel to dominant,0.045355564181891905,0.1517970941467468,0.06469572553908248,0.04081122325987374
32,Vaccine effectiveness in reducing infectiousness-0,0.009196589482568535,0.7714612109691027,-0.012488688820985487,0.6932499748822015
33,Vaccine effectiveness in reducing infectiousness-1,0.03529920057618347,0.26476037317872525,0.027717231281958434,0.3812650494064429
34,Ratio prob of hospitalization of novel to dominant,-0.005991047622284527,0.849921721217932,-0.013761117603046815,0.6638229876376353
35,Vaccine effectiveness against hospitalization-0,0.03144511188984315,0.3205229968631819,0.059436677247317236,0.06026317494494403
36,Vaccine effectiveness against hospitalization-1,-0.015590281458954145,0.62242154525391,0.009587313594574863,0.7620382860328183
37,Prob Hosp for 18-29,-0.00288805084072567,0.9273224310952816,0.035638507190874476,0.26019232168348705
38,Relative prob hosp by age-0,-0.0183412937216281,0.5623692629907263,-0.007634814902090246,0.8094500264650589
39,Relative prob hosp by age-1,0.08000460547216959,0.011378284675162536,0.026591979861070255,0.40090332023871555
40,Relative prob hosp by age-2,0.024069056138377294,0.4470821155766502,-0.0013701429347082643,0.965483472782728
41,Relative prob hosp by age-4,-0.03868890797433829,0.22156465369008993,0.01119878656797825,0.7235600565841874
42,Relative prob hosp by age-5,0.024717576929229414,0.4349318459048879,0.029152451507019762,0.3570900152001621
43,Relative prob hosp by age-6,0.025428146484938047,0.42184021528473475,0.02542569605697186,0.42188496218796834
44,Relative prob hosp by age-7,-0.0020512080183883404,0.9483461135713288,0.025866647043387432,0.4138776506229188
45,Duration of E-0,0.027862295221298128,0.3787769617658194,0.027759669523024957,0.38053612853909247
46,Duration of E-1,-0.028193387403857524,0.3731356716669116,0.0030264115358378243,0.9238509282763043
47,Duration of E-2,0.07753135867849369,0.01419136985807106,0.07400213095905281,0.019261258783860095
48,Duration of E-3,-0.044958114985068444,0.15542126242907073,0.01644857136750901,0.6033883515498114
49,Duration of I-0,-0.027928947963911523,0.37763710993573246,-0.004224899161933272,0.8938481506683028
50,Duration of I-1,0.03630995652120398,0.2513139188406839,0.02664951556602797,0.3998847037817919
51,Duration of I-2,-0.027928947963911523,0.37763710993573246,-0.004224899161933272,0.8938481506683028
52,Duration of I-3,0.03630995652120398,0.2513139188406839,0.02664951556602797,0.3998847037817919
53,Duration of Hosp-0,0.007763674021909104,0.806297270218132,0.023815062875942043,0.4518928010493025
54,Duration of Hosp-1,0.05646724177523376,0.07428697590526853,0.03798611493598748,0.23007829876926042
55,Duration of Hosp-2,0.02495844736179395,0.4304679881426162,-0.012725721236847707,0.6877314243971974
56,Duration of Hosp-3,0.017967030257578592,0.5703727785603312,0.022194722098853453,0.48326103664932596
57,Duration of R-0,0.0085785777311747,0.7864339960393425,-0.04615037062009181,0.1447428205066587
58,Duration of R-1,-0.007241457205643917,0.8190930987504401,0.013838448916871419,0.6620505902250189
59,Duration of R-2,0.006427546016613162,0.8391313341101571,-0.04791083227418397,0.13001363450981077
60,Duration of R-3,-0.004412460331095216,0.8891653572393443,0.015207911570023396,0.6309837479116003
61,Vaccination rate params-0,0.053811615894135106,0.08898491337565047,0.01439042233748268,0.6494549698724262
62,Vaccination rate params-1,-0.04293562180996352,0.17488575378794383,-0.07645480969612185,0.015596229463954118
63,Vaccination rate params-3,0.020184068213495512,0.5237712612309587,0.003136680940040437,0.9210852759988428
64,Vaccination rate t_min by age-1,-0.0017982942873794399,0.9547077165076031,-0.02143237088581259,0.4984179084571209
65,Vaccination rate t_min by age-2,-0.010404870227948016,0.7424366873677886,-0.021156990732470023,0.5039543628250055
66,Vaccination rate t_min by age-3,-0.05106214274902481,0.10657950302911186,-0.09727452591141142,0.0020731424856584462
67,Vaccination rate t_min by age-4,0.006478266929914378,0.8378794113630476,0.037395855443291846,0.23740613886572143
68,Vaccination rate t_min by age-5,0.013631866182337986,0.6667895621539349,-0.03684800352823322,0.24435343912144733
69,Vaccination rate t_min by age-6,0.0022549160280367006,0.9432245649285586,-0.005920563654995748,0.8516667994657305
70,Vaccination rate t_min by age-7,-0.019363358480890824,0.5407927392618607,-0.03194026889704952,0.31295825244901754
71,PD Y1 thresholds-0,0.017667055118960506,0.5768265381317942,0.03102660960183593,0.32700893402770037
72,PD Y1 thresholds-1,0.04162340703003944,0.18845229893948412,0.03295280964260435,0.2978575690557779
73,Change in contacts - PD Y1,0.019478103776242962,0.5383964281605501,-0.04911022053470278,0.1206632567942359
